Biotech Syndax Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Clinical and Business Update August 4, 2023
Biotech Precigen to Announce Second Quarter and First Half 2023 Financial Results on August 9th August 4, 2023
Biotech Complement Therapeutics Appoints Dr Parisa Zamiri MD, as Chief Medical Officer August 3, 2023
Biotech Kyverna Therapeutics Extends Series B Financing Round to $145 Million and Brings in New Investors August 3, 2023
Biotech MANA Develops Novel “Drycell” Microdroplets to Make Handling Single Cell Easier August 3, 2023
Biotech IDEAYA and Amgen Achieve First-Patient-In for Clinical Evaluation of IDE397 (MAT2A) and AMG 193 (PRMT5(MTA)) Combination in MTAP(-/-) Tumors August 2, 2023
Biotech Biocomposites appoints two new Directors to strengthen its team for its next phase of growth August 2, 2023
Biotech Atantares has Completed Two Rounds of RMB100 Million Financing, and the Pre-A Round is led by Asia Green Fund August 2, 2023